OSCIFLEX LLC

Developing technologies for venous disease based on molecular insights

Philadelphia, United States · Founded 2019 · $3.1M raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$3.1M
Last Round
$1.7M GrantJan 2022
Rounds
3

About

OsciFlex develops medical technologies for the prevention of venous thromboembolism (VTE) in hospitalized patients. Founded by researchers from the University of Pennsylvania, the company's OsciFlex System uses pneumatic actuation to drive rapid foot flexion and compression, stimulating calf muscle contraction to prevent dangerous blood clots. VTE is the leading cause of preventable hospital deaths in the US, affecting 300,000–600,000 patients annually.

Summary

OSCIFLEX LLC is a Biotech company based in Philadelphia, United States, founded in 2019. It has raised $3.1M in total across 3 rounds, most recently a $1.7M Grant round in Jan 2022. Investors include National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2022
$1000K

Sign up to see all 3 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OSCIFLEX LLC on Indexed.vc
<a href="https://indexed.vc/companies/osciflex-llc"><img src="https://indexed.vc/api/badge/company/osciflex-llc" alt="OSCIFLEX LLC on Indexed.vc" width="260" height="76" /></a>